Q1 2020 Holdings
Filed 2020-05-15 | 65 holdings | $313.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $183.0M | 1,681,645 | 58.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $61.9M | 1,052,969 | 19.8% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $20.8M | 698,118 | 6.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.9M | 344,937 | 4.4% |
| Apyx Med Corp(APYX) | COM | 03837C106 | $12.2M | 3,391,279 | 3.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $8.2M | 1,066,791 | 2.6% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $6.9M | 6,869,281 | 2.2% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.2M | 31,752 | 1.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $234.5K | 16,812,491 | 0.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $175.4K | 3,932,746 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $127.9K | 6,963,135 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $94.0K | 1,685,934 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $81.2K | 3,544,248 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $75.7K | 985,166 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $68.4K | 4,399,250 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $67.9K | 671,457 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $67.8K | 382,915 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $65.9K | 4,426,106 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $64.8K | 6,631,627 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $54.7K | 5,490,992 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $51.8K | 529,261 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $43.4K | 1,709,000 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $40.9K | 4,460,755 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $37.8K | 1,266,125 | 0.0% |
| Frequency Therapeutics Inc | COM | 35803L108 | $36.9K | 2,071,199 | 0.0% |
| Translate Bio Inc | COM | 89374L104 | $36.8K | 3,692,424 | 0.0% |
| Global Blood Therapeutics In | COM | 37890U108 | $36.8K | 719,489 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $36.6K | 780,898 | 0.0% |
| Avadel Pharmaceuticals plc | SPONSORED ADR | 05337M104 | $36.3K | 4,616,570 | 0.0% |
| Oyster Pt Pharma Inc | COM | 69242L106 | $33.9K | 969,478 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $33.6K | 984,542 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $33.5K | 2,319,138 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $32.1K | 13,096,625 | 0.0% |
| Wave Life Sciences Ltd(WVE) | SHS | Y95308105 | $31.8K | 3,389,933 | 0.0% |
| DermTech Inc(DMTKQ) | COM | 24984K105 | $29.1K | 2,600,729 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $28.6K | 443,725 | 0.0% |
| ProQR Thrapeutics N V | SHS EURO | N71542109 | $26.2K | 4,779,135 | 0.0% |
| NanoString Technologies Inc(NSTGEUR) | COM | 63009R109 | $25.5K | 1,059,621 | 0.0% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $21.8K | 675,650 | 0.0% |
| Exagen Inc(XGN) | COM | 30068X103 | $20.0K | 1,255,640 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $18.8K | 2,660,392 | 0.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $15.3K | 116,858 | 0.0% |
| 10x Genomics Inc(TXG) | CL A COM | 88025U109 | $11.8K | 190,109 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $10.2K | 313,606 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $10.1K | 366,085 | 0.0% |
| La Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $9.9K | 2,354,734 | 0.0% |
| MiMedx Group Inc(MDXG) | COM | 602496101 | $9.4K | 2,700,320 | 0.0% |
| Tela Bio Inc(TELA) | COM | 872381108 | $8.9K | 1,139,358 | 0.0% |
| Brainsway Ltd(BWAY) | SPONSORED ADS | 10501L106 | $8.8K | 1,107,420 | 0.0% |
| Milestone Pharmaceuticals In(MIST) | COM | 59935V107 | $7.9K | 4,315,102 | 0.0% |